drugset / Trial / NCT00273936
Trial of AVN-944 in Patients With Advanced Hematologic Malignancies
Non-randomizedSingle-groupOpen-label
Summary
The purpose of this study is to determine the safety and maximum tolerated dose, pharmacokinetics, and anti-neoplastic response of AVN-944 in patients with advanced hematologic malignancies.
Timeline
- Start
- 2006-01
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AVN944 | Small molecule | — | Oral |